Shots: Quebec government has stated province intention to shift towards biosimilars and follows the transition policies implemented by British Columbia, Alberta & New Brunswick The expanded use of biosimilars is […]readmore
Tags : British Columbia
Shots: Quebec will follow a similar approach to policies introduced in British Columbia, Alberta and recently in New Brunswick to transition patients who use a reference biologic to a biosimilar. […]readmore
Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and potency Biosimilars are expected to be a cost-effective alternative to the high-priced branded […]readmore
Shots: British Columbia and Health Minister Adrian Dix expand the biosimilar switching program to include Humira adalimumab and a new indication for Enbrel etanercept The expansion of the biosimilar switching […]readmore
Shots: BC decided to switch from reference product to biosimilars within 6 months, for patients suffering from diabetes, ankylosing spondylitis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis Post Nov 25,2019 […]readmore